Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Cash from Investing Activities (2017 - 2025)

Purple Biotech has reported Cash from Investing Activities over the past 6 years, most recently at $8.0 million for Q4 2022.

  • Quarterly Cash from Investing Activities rose 58.11% to $8.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $19.9 million through Dec 2022, up 48.55% year-over-year, with the annual reading at $632000.0 for FY2025, 24.17% up from the prior year.
  • Cash from Investing Activities was $8.0 million for Q4 2022 at Purple Biotech, up from $177000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $17.7 million in Q1 2022 and troughed at -$49.7 million in Q4 2020.
  • The 5-year median for Cash from Investing Activities is $5.0 million (2019), against an average of -$569818.2.
  • Year-over-year, Cash from Investing Activities plummeted 1088.33% in 2020 and then soared 1249.28% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at $5.1 million in 2018, then dropped by 1.12% to $5.0 million in 2019, then plummeted by 1088.33% to -$49.7 million in 2020, then soared by 110.18% to $5.1 million in 2021, then skyrocketed by 58.11% to $8.0 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Cash from Investing Activities are $8.0 million (Q4 2022), $177000.0 (Q3 2022), and -$6.0 million (Q2 2022).